ImmuCell Corporation revenue for the last year amounted to 19.24 M USD, the most of which — 17.29 M USD — came from its highest performing source at the moment, Scours, the year earlier bringing 18.41 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ImmuCell Corporation 15.95 M USD, and the year before that — 17.02 M USD.